# Barclays - Bayesian Update: Post-Tier 2

## Prior State (Post-Tier 1)
| Metric | Value |
|--------|-------|
| P(Architect) | 75% |
| P(Pragmatist) | 25% |

## Tier 2 Evidence

| ID | Claim | LR | Direction |
|----|-------|-----|-----------|
| BARC-003 | Lee Braine CDM advocacy | 3.0 | SUPPORTS |
| BARC-005 | G-SIBs CDM pilot confirmation | 4.0 | SUPPORTS |
| BARC-006 | Risk Awards 2024 | 1.3 | NEUTRAL |

## Bayesian Calculation

### Step 1: Calculate Combined Likelihood Ratio
```
LR_combined = 3.0 × 4.0 × 1.3 = 15.6
```

### Step 2: Apply Temporal Weighting
| Evidence | Age | Weight |
|----------|-----|--------|
| BARC-003 | Historical (2018) | 0.3 |
| BARC-005 | Current (2024) | 1.0 |
| BARC-006 | Current (2024) | 1.0 |

```
LR_weighted = (3.0^0.3) × (4.0^1.0) × (1.3^1.0)
LR_weighted = 1.39 × 4.0 × 1.3
LR_weighted = 7.23
```

### Step 3: Update Probability
```
Prior odds = 0.75 / 0.25 = 3.0
Posterior odds = 3.0 × 7.23 = 21.69
P(Architect) = 21.69 / (1 + 21.69) = 95.6%
```

### Step 4: Apply Confidence Cap
Maximum: 75% (no Tier 1 production evidence)

## Posterior State

| Metric | Before | After |
|--------|--------|-------|
| P(Architect) | 75% | 75% (capped) |
| P(Pragmatist) | 25% | 25% |

## Analysis

Tier 2 evidence strongly reinforces the CDM Advocate pattern:
- Lee Braine's advocacy confirms internal strategic interest
- RegRisk confirmation places Barclays in CDM pilot cohort with GS, JPM, BNP
- Derivatives awards confirm market position (capability to adopt)

However, the cap remains at 75% due to:
1. No FINOS membership
2. No production DRR announcement
3. "Pilot" status explicitly confirmed (not "production")

---
*Bayesian Update Complete*
*P(Architect) = 75% (capped)*
*Generated: 2025-12-21*
